Lek Launches Development Centre for Biopharmaceuticals
Mengeš, 4 October - Drug maker Lek on Thursday launched a development centre for biopharmaceuticals, one of six such centres in the Novartis group. The EUR 7m facility will strengthen the position of Lek and Sandoz in biopharmacy, Lek chairman Vojmir Urlep said.
The rest of this news item is available to subscribers.
The news item consists of 639 characters (without spaces) or 118 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.